Total Splenectomy vs Partial Splenectomy in Non-malignant Hemoglobinopathies : Study Comparing the Effectiveness
NCT05184647 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-01-11
Summary
Partial splenectomy or total splenectomy are the two surgical treatment of non-malignant hemoglobinoptahie. The aim of this treatment is to decrease transfusion. The main risk is infectious in total splenectomy, that's why partial splenectomy was suggest. But the efficiency of partial splenectomy decrease over time and a totalisation could be mandatory.
Conditions
- Splenectomy; Status
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Nicolas KALFA · University Hospital, Montpellier
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-16
- Primary Completion
- 2022-06-30
- Completion
- 2022-12-30
Countries
- France
Study Locations
More Related Trials
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3
-
Beta-thalassemia and Microparticles
NCT01284738 ·Status: COMPLETED ·Phase: NA
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
NCT02435901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
NCT05440838 ·Status: RECRUITING
-
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
NCT03240731 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes
NCT02855957 ·Status: COMPLETED ·Phase: NA
-
A Nationwide Italian Survey on Asplenia
NCT03571399 ·Status: COMPLETED
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Immunopathology of Autoimmune Hemolytic Anemia
NCT02158195 ·Status: COMPLETED
-
Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease
NCT01522547 ·Status: COMPLETED ·Phase: PHASE1
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING
-
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694 ·Status: COMPLETED
-
The Dallas Hereditary Spherocytosis Cohort Study
NCT01141621 ·Status: TERMINATED
-
Inflammation, Platelets and Sickle Cell Disease
NCT05646888 ·Status: ACTIVE_NOT_RECRUITING
-
Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
NCT00202436 ·Status: COMPLETED ·Phase: PHASE3
-
Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
NCT02126046 ·Status: UNKNOWN ·Phase: NA
-
In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
NCT02986698 ·Status: TERMINATED ·Phase: PHASE1
-
Allograft for Sickle Cell Disease and Thalassemia
NCT02038478 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound
NCT02829580 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Study of a Deformability Parameter of Red Blood Cell
NCT05850156 ·Status: NOT_YET_RECRUITING
-
Spectrum of Hematological Disorders in Pediatrics
NCT05473650 ·Status: UNKNOWN
-
Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major
NCT04367701 ·Status: COMPLETED
-
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2